These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 15917377

  • 1. A Bayesian mixture model relating dose to critical organs and functional complication in 3D conformal radiation therapy.
    Johnson TD, Taylor JM, Ten Haken RK, Eisbruch A.
    Biostatistics; 2005 Oct; 6(4):615-32. PubMed ID: 15917377
    [Abstract] [Full Text] [Related]

  • 2. Bayesian generalized monotonic functional mixed models for the effects of radiation dose histograms on normal tissue complications.
    Schipper M, Taylor JM, Lin X.
    Stat Med; 2007 Nov 10; 26(25):4643-56. PubMed ID: 17407198
    [Abstract] [Full Text] [Related]

  • 3. A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients.
    Houweling AC, Philippens ME, Dijkema T, Roesink JM, Terhaard CH, Schilstra C, Ten Haken RK, Eisbruch A, Raaijmakers CP.
    Int J Radiat Oncol Biol Phys; 2010 Mar 15; 76(4):1259-65. PubMed ID: 20005639
    [Abstract] [Full Text] [Related]

  • 4. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
    Blanco AI, Chao KS, El Naqa I, Franklin GE, Zakarian K, Vicic M, Deasy JO.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1055-69. PubMed ID: 15990009
    [Abstract] [Full Text] [Related]

  • 5. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
    Dijkema T, Terhaard CH, Roesink JM, Braam PM, van Gils CH, Moerland MA, Raaijmakers CP.
    Int J Radiat Oncol Biol Phys; 2008 Nov 15; 72(4):1101-9. PubMed ID: 18472355
    [Abstract] [Full Text] [Related]

  • 6. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
    Jellema AP, Doornaert P, Slotman BJ, Leemans CR, Langendijk JA.
    Radiother Oncol; 2005 Nov 15; 77(2):164-71. PubMed ID: 16256229
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
    Lee EK, Fox T, Crocker I.
    Int J Radiat Oncol Biol Phys; 2006 Jan 01; 64(1):301-20. PubMed ID: 16289912
    [Abstract] [Full Text] [Related]

  • 9. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
    Nishimura Y, Nakamatsu K, Shibata T, Kanamori S, Koike R, Okumura M, Suzuki M.
    Jpn J Clin Oncol; 2005 Jul 01; 35(7):375-9. PubMed ID: 15976068
    [Abstract] [Full Text] [Related]

  • 10. Intensity-modulated radiation therapy in the treatment of head and neck cancer.
    Eisbruch A.
    Nat Clin Pract Oncol; 2005 Jan 01; 2(1):34-9. PubMed ID: 16264854
    [Abstract] [Full Text] [Related]

  • 11. Intensity-modulated radiation therapy for head and neck cancer.
    Chou WW, Puri DR, Lee NY.
    Expert Rev Anticancer Ther; 2005 Jun 01; 5(3):515-21. PubMed ID: 16001958
    [Abstract] [Full Text] [Related]

  • 12. Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer.
    Saarilahti K, Kouri M, Collan J, Kangasmäki A, Atula T, Joensuu H, Tenhunen M.
    Radiother Oncol; 2006 Mar 01; 78(3):270-5. PubMed ID: 16564589
    [Abstract] [Full Text] [Related]

  • 13. Intensity-modulated radiation therapy and xerostomia.
    Chambers MS, Weber RS, Garden AS.
    J Calif Dent Assoc; 2006 Sep 01; 34(9):743-8. PubMed ID: 17022299
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Volume effects and region-dependent radiosensitivity of the parotid gland.
    Konings AW, Cotteleer F, Faber H, van Luijk P, Meertens H, Coppes RP.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1090-5. PubMed ID: 15990013
    [Abstract] [Full Text] [Related]

  • 17. Three-dimensional conformal radiotherapy for locally advanced (Stage II and worse) head-and-neck cancer: dosimetric and clinical evaluation.
    Portaluri M, Fucilli FI, Castagna R, Bambace S, Pili G, Tramacere F, Russo D, Francavilla MC.
    Int J Radiat Oncol Biol Phys; 2006 Nov 15; 66(4):1036-43. PubMed ID: 16750321
    [Abstract] [Full Text] [Related]

  • 18. Effect of Cisplatin on parotid gland function in concomitant radiochemotherapy.
    Hey J, Setz J, Gerlach R, Vordermark D, Gernhardt CR, Kuhnt T.
    Int J Radiat Oncol Biol Phys; 2009 Dec 01; 75(5):1475-80. PubMed ID: 19515505
    [Abstract] [Full Text] [Related]

  • 19. Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data.
    Semenenko VA, Li XA.
    Phys Med Biol; 2008 Feb 07; 53(3):737-55. PubMed ID: 18199912
    [Abstract] [Full Text] [Related]

  • 20. The role of saliva in oral health: strategies for prevention and management of xerostomia.
    Brosky ME.
    J Support Oncol; 2007 May 07; 5(5):215-25. PubMed ID: 17564151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.